Johnson & Johnson (JNJ) Non Operating Income (2009 - 2026)
Johnson & Johnson recorded quarterly Non Operating Income of -$294.0 million in Q1 2026, up 39.13% quarter-over-quarter from -$483.0 million in Q4 2025, and down 104.02% year-over-year from $7.3 billion in Q1 2025.
Johnson & Johnson's Non Operating Income history runs 18 years deep, the most recent figure standing at -$294.0 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 104.02% year-over-year to -$294.0 million; the TTM figure through Mar 2026 stood at -$406.0 million (down 108.07% YoY), while the FY2025 annual figure was $7.2 billion, up 253.58% from the prior year.
- Non Operating Income came in at -$294.0 million for Q1 2026 at Johnson & Johnson, up from -$483.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $7.3 billion in Q1 2025 to a low of -$6.9 billion in Q2 2023.
- A 5-year average of -$302.4 million and a median of -$273.0 million in 2022 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income plunged 6903.92% in 2023 and soared 404.53% in 2025, its largest moves.
- Johnson & Johnson's Non Operating Income stood at -$226.0 million in 2022, then soared by 286.28% to $421.0 million in 2023, then tumbled by 61.76% to $161.0 million in 2024, then tumbled by 400.0% to -$483.0 million in 2025, then soared by 39.13% to -$294.0 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$294.0 million, -$483.0 million, and $478.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -65.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -294.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -2.31 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -138.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 235.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -861.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -32.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -294.00 Mn |
| Dec 28, 2025 | -483.00 Mn |
| Sep 28, 2025 | 478.00 Mn |
| Jun 29, 2025 | -107.00 Mn |
| Mar 30, 2025 | 7.32 Bn |
| Dec 29, 2024 | 161.00 Mn |
| Sep 29, 2024 | -1.80 Bn |
| Jun 30, 2024 | -653.00 Mn |
| Mar 31, 2024 | -2.40 Bn |
| Dec 31, 2023 | 421.00 Mn |
| Oct 1, 2023 | -499.00 Mn |
| Jul 2, 2023 | 384.00 Mn |
| Apr 2, 2023 | -6.94 Bn |
| Jan 1, 2023 | -330.00 Mn |
| Oct 2, 2022 | -226.00 Mn |
| Jul 3, 2022 | -273.00 Mn |
| Apr 3, 2022 | 102.00 Mn |
| Oct 3, 2021 | -1.85 Bn |
| Jul 4, 2021 | 488.00 Mn |
| Apr 4, 2021 | 882.00 Mn |
| Jan 3, 2021 | -2.35 Bn |
| Sep 27, 2020 | -1.20 Bn |
| Jun 28, 2020 | -24.00 Mn |
| Mar 29, 2020 | 679.00 Mn |
| Dec 29, 2019 | -16.00 Mn |
| Sep 29, 2019 | -4.21 Bn |
| Jun 30, 2019 | 1.68 Bn |
| Mar 31, 2019 | 300.00 Mn |
| Dec 30, 2018 | -978.00 Mn |
| Sep 30, 2018 | -3.00 Mn |
| Jul 1, 2018 | -364.00 Mn |
| Apr 1, 2018 | -60.00 Mn |
| Dec 31, 2017 | 53.00 Mn |
| Oct 1, 2017 | 297.00 Mn |
| Jul 2, 2017 | -527.00 Mn |
| Apr 2, 2017 | 219.00 Mn |
| Jan 1, 2017 | -1.07 Bn |
| Oct 2, 2016 | 54.00 Mn |
| Jul 3, 2016 | -557.00 Mn |
| Apr 3, 2016 | 39.00 Mn |
| Sep 27, 2015 | -420.00 Mn |
| Jun 28, 2015 | 931.00 Mn |
| Mar 29, 2015 | 348.00 Mn |
| Dec 28, 2014 | -963.00 Mn |
| Sep 28, 2014 | 1.35 Bn |
| Jun 29, 2014 | -226.00 Mn |
| Mar 30, 2014 | -86.00 Mn |
| Dec 29, 2013 | -868.00 Mn |
| Sep 29, 2013 | -943.00 Mn |
| Jun 30, 2013 | -172.00 Mn |
| Mar 31, 2013 | -515.00 Mn |
| Dec 30, 2012 | -319.00 Mn |
| Sep 30, 2012 | 90.00 Mn |
| Jul 1, 2012 | -2.01 Bn |
| Apr 1, 2012 | 611.00 Mn |
| Jan 1, 2012 | -4.61 Bn |
| Oct 2, 2011 | 308.00 Mn |
| Jul 3, 2011 | -206.00 Mn |
| Apr 3, 2011 | 13.00 Mn |
| Oct 3, 2010 | 292.00 Mn |
| Jul 4, 2010 | -18.00 Mn |
| Apr 4, 2010 | 1.59 Bn |
| Jan 3, 2010 | 361.00 Mn |
| Sep 27, 2009 | 96.00 Mn |
| Jun 28, 2009 | 6.00 Mn |
| Mar 29, 2009 | 75.00 Mn |